Founder Bill Wells To Retire
24/05/2022 23:18
May 24 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS EXECUTIVE CHAIRMAN AND CO-FOUNDER BILL
WELLS TO
RETIRE
* HLS THERAPEUTICS INC - GREG GUBITZ HAS BEEN APPOINTED
CHAIR OF
BOARD EFFECTIVE IMMEDIATELY
* HLS THERAPEUTICS INC - WELLS INTENDS TO FOCUS ON OTHER
BUSINESS
INTERESTS AND HAS AGREED TO WORK WITH CO TO FACILITATE AN
ORDERLY TRANSITION
Source text for Eikon: ID:nCNWW90QWa
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease